Stuart Diamond's most recent trade in BioAffinity Technologies Inc was a trade of 33,784 Common Stock done . Disclosure was reported to the exchange on July 1, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
BioAffinity Technologies Inc | Stuart Diamond | Director | 01 Jul 2024 | 33,784 | 99,088 | - | 0 | Common Stock | ||
BioAffinity Technologies Inc | Stuart Diamond | Director | 12 Jun 2024 | 8,296 | 65,304 | - | 0 | Common Stock | ||
BioAffinity Technologies Inc | Diamond Stuart | Director | 01 Oct 2023 | 12,668 | 57,008 | - | 1.5 | 18,749 | Common Stock | |
BioAffinity Technologies Inc | Diamond Stuart | Director | 01 Oct 2023 | 11,867 | 44,340 | - | 1.6 | 18,750 | Common Stock | |
BioAffinity Technologies Inc | Stuart Diamond | Director | 01 Jan 2023 | 10,245 | 32,473 | - | 1.8 | 18,748 | Common Stock | |
BioAffinity Technologies Inc | Stuart Diamond | Director | 01 Jan 2023 | 9,920 | 22,228 | - | 1.9 | 18,749 | Common Stock | |
BioAffinity Technologies Inc | Stuart Diamond | Director | 01 Jan 2023 | 8,227 | 12,308 | - | 2.3 | 18,758 | Common Stock | |
BioAffinity Technologies Inc | Stuart Diamond | Director | 31 Aug 2022 | 4,081 | 4,081 | - | - | Common Stock, par value $0.007 | ||
BioAffinity Technologies Inc | Stuart Diamond | Director | 31 Aug 2022 | 4,081 | 4,081 | - | - | Warrants (right to buy) | ||
BioAffinity Technologies Inc | Stuart Diamond | Director | 31 Aug 2022 | 4,081 | 4,081 | - | - | Non-tradeable Warrants (right to buy) |